Efficacy evaluation of Overflow leak test by 30 mL intrathecal injectio
Phase 2
Recruiting
- Conditions
- cerebrospinal fluid hypovolemia
- Registration Number
- JPRN-jRCTs061220082
- Lead Sponsor
- akai Eiichi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
1. Patients with low cerebrospinal fluid pressure (patients whose cerebrospinal fluid pressure of 60 mmH2O or less has been confirmed even once)
2. Patients over 18 years old
3. Persons who have obtained written consent from the person concerned (in the case of minors and persons who lack consent ability)
Exclusion Criteria
1. Patients who tend to bleed
2. Patients who have difficulty with lumbar puncture
3. Pregnant woman
4. Patients recognized by doctors as ineligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the rate at which the leak site could be identified by CT myelography images and the rate at which the leak site could be identified by the 30 mL intrathecal injection Overflow leak test
- Secondary Outcome Measures
Name Time Method (1) Comparison of the rate at which the leak site could be identified by CT myelography images and the rate at which the leak site could be identified by the Overflow leak test (including discontinued cases)<br>(2) Changes in MRI images before and after the Overflow leak test